Susquehanna International Group, LLP Forte Biosciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.02 - $3.36 $9,898 - $16,464
-4,900 Reduced 8.26%
54,400 $116,000
Q3 2021

Nov 15, 2021
BUY
$2.96 - $36.67 $114,552 - $1.42 Million
38,700 Added 187.86%
59,300 $176,000
Q2 2020

Aug 14, 2020
BUY
$13.9 - $24.6 $286,340 - $506,760
20,600 New
20,600 $300,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email